Anxiety

Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders

Elizabeth Whittaker, Alisher R. Dadabayev, Sonalee A. Joshi, Paul Glue Published 15 December 2021| https://doi.org/10.1177/20451253211056743 Abstract Background: Anxiety disorders are common, associated with significant burden of disease, and have high levels of treatment resistance. Low-dose ketamine has been extensively studied in treatment-resistant depression, with fewer reports in treatment-resistant anxiety disorders. Aims: This systematic review and […]

Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders Read More »

Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders

Paul Glue, Shona M Neehoff, Natalie J Medlicott, Andrew Gray, Guy Kibby, Neil McNaughton First Published March 21, 2018 | https://doi.org/10.1177/0269881118762073 Abstract Objective: In this maintenance treatment study, we sought to evaluate the effect on anxiety ratings, safety and tolerability of 3 months of weekly ketamine in 20 patients with treatment-refractory DSM IV generalised anxiety disorder

Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders Read More »

Vice News: Does NAD+ Really Work

NAD+ is popular among the “anti-aging community,” thanks to a Harvard Medical School study that found it rewound “aspects of age-related demise in mice.” It’s also supposedly good for: detoxing from alcohol and drugs, increasing energy and focus, reducing chronic fatigue, increasing your metabolism, and improving your cardiovascular health.

Vice News: Does NAD+ Really Work Read More »

Scroll to Top